NCT01796457View on ClinicalTrials.gov

HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B

Active, not recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Hepatitis B
Trial Locations (8)

23298

Virginia Commonwealth University Medical Center, Richmond

55446

University of Minnesota, Plymouth

94115

California Pacific Medical Center, San Francisco

94143

University of California San Francisco Medical Center, San Francisco

98101

Virginia Mason Medical Center, Seattle

98104

Harborview Medical Center, Seattle

02115

Beth Israel Deaconess Medical Center, Boston

Unknown

Toronto Western Hospital Liver Centre, Toronto

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Pennsylvania

OTHER

NCT01796457 - HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B | Biotech Hunter | Biotech Hunter